Evogene (EVGN) Reports Q2 Loss of $0.31/Share
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Evogene (NYSE: EVGN) reported Q2 EPS of ($0.31), versus ($0.33) reported last year. Revenue for the quarter came in at $3.82 million, versus $5.36 million reported last year.
For earnings history and earnings-related data on Evogene (EVGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Gold (ABX) Tops Q3 EPS by 4c
- Deltic Timber Corp. (DEL) Reports Q3 EPS of $0.12
- Antero Midstream Partners (AM) Tops Q3 EPS by 5c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!